Quratis Inc.

Quratis Inc. is a South Korean company that develops vaccines. Its pipeline includes QTP101 for tuberculosis, QTP104, a next-generation mRNA vaccine, a cell-penetrating peptide (CPP) platform for drug delivery into cells and bacteria, and peptide nucleic acid (PNA), a synthetic analogue of DNA. The company also provides contract development and manufacturing services for drugs. Quratis Inc. was incorporated in 2016 and is based in Cheongju-si, South Korea.